摘要:
springer.com 
sci-hub.st 参考文章(37)
RL Souhami, , K Law, Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. British Journal of Cancer. ,vol. 61, pp. 584- 589 ,(1990) , 10.1038/BJC.1990.131
N Murray, P Coy, J L Pater, I Hodson, A Arnold, B C Zee, D Payne, E C Kostashuk, W K Evans, P Dixon, Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 11, pp. 336- 344 ,(1993) , 10.1200/JCO.1993.11.2.336
P Warde, D Payne, Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. Journal of Clinical Oncology. ,vol. 10, pp. 890- 895 ,(1992) , 10.1200/JCO.1992.10.6.890
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
W Curran, C Scott, C Langer, R Komaki, J Lee, S Hauser, B Movsas, T Wasserman, A Russell, R Byhardt, W Sause, J Cox, Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 Lung Cancer. ,vol. 29, pp. 93- ,(2000) , 10.1016/S0169-5002(00)80304-9
Thomas E. Stinchcombe, Lydia Hodgson, James E. Herndon, Michael J. Kelley, M Giulia Cicchetti, Nithya Ramnath, Harvey B. Niell, James N. Atkins, Wallace Akerley, Mark R. Green, Everett E. Vokes, Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. Journal of Thoracic Oncology. ,vol. 4, pp. 1117- 1125 ,(2009) , 10.1097/JTO.0B013E3181B27B33
Everett E. Vokes, Suresh Senan, Joseph A. Treat, Neill A. Iscoe, PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histology. Clinical Lung Cancer. ,vol. 10, pp. 193- 198 ,(2009) , 10.3816/CLC.2009.N.027
Mark R. Green, Howard West, Mark A. Socinski, Joanne Willey, Laura Daniels, Kristine Lemke, George Rafferty, Lou Iovino, Impact of the ASCO 2007 Presentation of HOG Lun 01-24/USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 4, pp. 983- 987 ,(2009) , 10.1097/JTO.0B013E3181ADEEFB
Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara, Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 26, pp. 3543- 3551 ,(2008) , 10.1200/JCO.2007.15.0375
Federico Cappuzzo, Tudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, Aleksandra Szczésna, Erzsébet Juhász, Emilio Esteban, Olivier Molinier, Wolfram Brugger, Ivan Melezínek, Gaëlle Klingelschmitt, Barbara Klughammer, Giuseppe Giaccone, Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study Lancet Oncology. ,vol. 11, pp. 521- 529 ,(2010) , 10.1016/S1470-2045(10)70112-1